HBV antiviral treatment linked with reduced cirrhosis risk

Patients with chronic hepatitis B who received antiviral therapy experienced a significant reduction in risk for cirrhosis, according to study results.“Few studies have specifically focused on the benefits of HBV antiviral therapies in non-Asian and noncirrhotic cohorts, especially as it relates to evaluating the impact of treatment on the risk of developing cirrhosis and death,” Robert J. Wong, MD, from Veterans Affairs Palo Alto Healthcare System, and colleagues wrote. “Furthermore, limited studies exist specifically focusing on safety-net and vulnerable populations,Read More

Share on facebook
Share on twitter
Share on linkedin